Skip to main content

Advertisement

Table 3 Comparison of clinical and economic outcomes in overall cohort

From: Cost-consequence analysis of salvianolate injection for the treatment of coronary heart disease

Outcome Conventional treatment + salvianolate injection (n = 401) Conventional treatment (n = 401) Difference P
Hospital stay (days) 11.7 (± 7.5) 14.6 (± 11.5) − 2.9 < 0.05
Total nitrates dosage (mg) 457.7 (± 511.4) 630.1 (± 650.4) − 172.4 < 0.05
Total medical costs (CNY) 14,726.3 (± 18,165.8) 17,362.7 (± 22,161.8) − 2636.4 0.054
Subcategories costs (CNY)
 Supplies cost 5538.6 (± 13,486.6) 5770.9 (12,458.5) − 232.3 0.801
 Pharmacy cost 3122.5 (± 3124.2) 4890.1 (± 5218.0) − 1767.6 < 0.05
 Examination cost 1410.6 (± 1277.5) 1954.9 (± 2427.2) − 544.3 < 0.05
 Laboratory cost 1351.7 (± 818.3) 1564.2 (± 1330.3) − 212.5 < 0.05
 Operation cost 2626.2 (± 1884.2) 4223.2 (± 3211.2) − 1597.0 < 0.05
 Treatment cost 447.4 (± 831.6) 1005.7 (± 1687.1) − 558.3 < 0.05
 Chinese patent drug cost 1316.6 (± 581.0) 141.7 (± 474.6) 1174.9 < 0.05